RTW Investments is making a licensing deal with a China biotech for an antibody that’s being developed for two related autoimmune conditions called Graves’ disease and thyroid eye disease.
As part of the deal, RTW …
Empower Pharmacy, a large GLP-1 compounding pharmacy that’s faced allegations of poor quality drugs and a legal challenge from Eli Lilly, has stopped operations at
The European Commission has unveiled a long-awaited proposal to make Europe a “biotech powerhouse” by speeding up clinical trials, extending intellectual property protection and boosting
The Biosecure Act is slated to become law after the Senate on Wednesday passed a defense bill that includes the measure. It’s a development that
HHS Secretary Robert F. Kennedy Jr. added two conditions to a federal newborn screening list, reviving efforts that had been stalled under the Trump administration
The CDC adopted new hepatitis B vaccine recommendations, eliminating the universal birth dose guidance that had been on the books for decades. The agency now
RTW Investments is making a licensing deal with a China biotech for an antibody that’s being developed for two related autoimmune conditions called Graves’ disease and thyroid eye disease.
As part of the deal, RTW …